Kellanova Form 4 insider transactions
Kellanova Director Stephanie Burns reported the acquisition of 163.91 phantom stock units under a deferred compensation plan, effective August 15, 2025.
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova common stock for approximately $9.17 million, reducing its beneficial ownership to 45,326,620 shares.
The W.K. Kellogg Foundation Trust, a 10% owner of Kellanova, sold 114,583 shares of common stock for $79.97 per share, pursuant to a pre-planned Rule 10b5-1 trading plan.
The W.K. Kellogg Foundation Trust reported the sale of 114,583 shares of Kellanova common stock for approximately $9.14 million, executed under a pre-arranged 10b5-1 trading plan.
The W.K. Kellogg Foundation Trust filed an amended Form 4 to correct the average sale price of 114,583 Kellanova common shares sold on July 21, 2025, to $79.8697.
The W.K. Kellogg Foundation Trust, a 10% owner of Kellanova, has filed a Form 4 indicating a future sale of 114,583 common shares at $79.92 per share, executed under a pre-arranged 10b5-1 trading plan.
The W.K. Kellogg Foundation Trust, a 10% owner of Kellanova, reported the sale of 114,583 shares of common stock at $79.5442 per share, executed under a pre-arranged 10b5-1 trading plan.
Form 4: W.K. Kellogg Foundation Trust Sells Over 114,000 Kellanova Shares in Pre-Planned Transaction
The W.K. Kellogg Foundation Trust, a 10% owner and director of Kellanova, reported the sale of 114,583 shares of common stock for approximately $9.13 million, executed under a pre-arranged Rule 10b5-1 trading plan.
The W.K. Kellogg Foundation Trust, a 10% owner and director of Kellanova, has filed a Form 4 indicating a planned sale of 114,583 shares of common stock on June 30, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Form 4: W.K. Kellogg Foundation Trust Sells Over 114,000 Shares of Kellanova Stock Under Pre-Arranged Plan
The W.K. Kellogg Foundation Trust, a significant shareholder and director of Kellanova, has sold 114,583 shares of common stock for approximately $78.42 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
The W.K. Kellogg Foundation Trust, a significant 10% owner and director of Kellanova, reported the sale of 114,583 shares of common stock on June 16, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
Form 4: W.K. Kellogg Foundation Trust Sells Over 114,000 Shares of Kellanova Stock Under Pre-Arranged Plan
The W.K. Kellogg Foundation Trust, a 10% owner and director of Kellanova, reported the sale of 114,583 shares of common stock for approximately $9.38 million, executed under a Rule 10b5-1 trading plan.
Form 4: W.K. Kellogg Foundation Trust Sells Over 114,000 Shares of Kellanova Stock Under Pre-Arranged Plan
The W.K. Kellogg Foundation Trust, a significant shareholder of Kellanova, reported the sale of 114,583 shares of common stock for approximately $9.4 million, executed under a pre-scheduled 10b5-1 trading plan.
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.244 per share on May 21, 2025, according to a Form 4 filing.
Director Zachary Gund reports changes in beneficial ownership of Kellanova shares, including holdings in trusts and family partnerships.
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $81.7942 per share on May 14, 2025, according to a Form 4 filing.
Director Stephanie Burns reports changes in beneficial ownership of Kellanova stock, including phantom stock units, as of May 14, 2025.
Director Zachary Gund reports acquiring 2,119 shares of Kellanova common stock at $82.61 per share and updates beneficial ownership details.
Director Tabron La June Montgomery increased their holdings in Kellanova through a trust, acquiring 2,119 shares at $82.61 each.
Director Donald R. Knauss reports the acquisition of 2,119 shares of Kellanova common stock at $82.61 per share on May 5, 2025.
Director Mary A. Laschinger reports the acquisition of 2,119 shares of Kellanova common stock at $82.61 per share on May 5, 2025.
Director Erica L. Mann reported the acquisition of Kellanova shares through a trust on May 5, 2025.
Director Carter A. Cast reports acquisition of Kellanova shares held in trust.
Director Stephanie Burns increased her holdings in Kellanova through a transaction on May 5, 2025.
Director Roderick D. Gillum reports the acquisition of 2,119 shares of Kellanova common stock at $82.61 per share on May 5, 2025.
Director J Michael Schlotman reports acquiring 2,119 shares of Kellanova common stock at $82.61 per share on May 5, 2025.
Director Carolyn M. Tastad acquired 2,119 shares of Kellanova common stock at $82.61 per share on May 5, 2025.
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock at a price of $82.558 per share on May 7, 2025, according to a Form 4 filing.
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.4727 per share on April 28, 2025, according to a Form 4 filing.
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2574 per share on April 21, 2025, according to a Form 4 filing.